Annexon, Inc. (NASDAQ:ANNX) Stock Holdings Increased by Mutual of America Capital Management LLC

Mutual of America Capital Management LLC raised its holdings in shares of Annexon, Inc. (NASDAQ:ANNX) by 56.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,029,680 shares of the company’s stock after acquiring an additional 370,426 shares during the period. Mutual of America Capital Management LLC’s holdings in Annexon were worth $5,282,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in ANNX. China Universal Asset Management Co. Ltd. acquired a new position in shares of Annexon during the 4th quarter valued at $116,000. Quarry LP acquired a new position in shares of Annexon during the 3rd quarter valued at $118,000. Intech Investment Management LLC acquired a new position in shares of Annexon during the 3rd quarter valued at $154,000. New York State Common Retirement Fund increased its position in shares of Annexon by 143.4% during the 4th quarter. New York State Common Retirement Fund now owns 34,479 shares of the company’s stock valued at $177,000 after purchasing an additional 20,311 shares during the period. Finally, GSA Capital Partners LLP increased its position in shares of Annexon by 10.7% during the 3rd quarter. GSA Capital Partners LLP now owns 34,581 shares of the company’s stock valued at $205,000 after purchasing an additional 3,355 shares during the period.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on ANNX. HC Wainwright reiterated a “buy” rating and set a $30.00 price target on shares of Annexon in a research report on Tuesday, December 17th. Needham & Company LLC reiterated a “buy” rating and set a $16.00 price target on shares of Annexon in a research report on Friday, November 15th. Finally, Cantor Fitzgerald reiterated an “overweight” rating on shares of Annexon in a research report on Friday, November 15th. Six research analysts have rated the stock with a buy rating, According to MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus target price of $15.80.

Annexon Stock Down 9.5 %

Shares of NASDAQ ANNX opened at $2.39 on Tuesday. The stock has a market capitalization of $254.76 million, a price-to-earnings ratio of -2.28 and a beta of 1.07. The stock’s fifty day simple moving average is $4.01 and its 200 day simple moving average is $5.45. Annexon, Inc. has a 52-week low of $2.39 and a 52-week high of $8.40.

Annexon (NASDAQ:ANNX) last issued its earnings results on Monday, March 3rd. The company reported ($0.33) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.28) by ($0.05). As a group, analysts anticipate that Annexon, Inc. will post -0.96 earnings per share for the current year.

Annexon Company Profile

Annexon, Inc, a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases. Its lead candidate is ANX005, an investigational full-length monoclonal antibody, which is in Phase 3 clinical trial for the treatment of patients with guillain-barré syndrome; completed Phase II clinical trial for treating Huntington's disease; and in Phase II clinical trial for the treatment of amyotrophic lateral sclerosis.